-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cognition Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q3 2025.
- Cognition Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 78M shares, a 92.9% increase year-over-year.
- Cognition Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 39.7M shares, a 32.3% increase from 2023.
- Cognition Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 30M shares, a 27% increase from 2022.
- Cognition Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 23.6M shares, a 355% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)